…
NeuPath Health Inc. provides chronic pain management services in Canada. It operates a network of medical clinics in Ontario and Alberta that offer assessments and rehabilitation services to patients with chronic pain, musculoskeletal/back injuries, sports-related injuries, and concussions. The company also provides workplace health services and independent medical assessments to employers and disability insurers, as well as legal practices through a network of health care providers comprising cardiologists, dentists, dermatologists, endocrinologists, psychiatrists, gastroenterologists, general practitioners, internal medicine specialists, neurologists, neuropsychiatrists, neuropsychologists, occupational therapists, ophthalmologists, orthopedic surgeons, physiatrists, physiotherapists, psychologists, respirologists, and rheumatologists. In addition, it operates a network of healthcare clinics and related businesses. The company is headquartered in Mississauga, Canada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public information on NeuPath Health Inc. (NPTH.V) is limited; the company is listed on the TSX Venture Exchange but detailed operations and financials are not readily available. If it operates in healthcare services or technologies, long-term growth drivers could include ageing populations, rising healthcare spending and demand for new care-delivery solutions, which may make sector exposure attractive despite disclosure gaps.
Key risks are limited disclosure, low liquidity, execution and financing risks typical of small-cap healthcare issuers, plus regulatory and reimbursement uncertainty.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -0.06M | -0.27M | 0.06M | -4.08M | -3.25M |
| Minority interest | -0.30M | -0.24M | 0.08M | 0.13M | - |
| Net income | -0.72M | -0.73M | -0.11M | -4.17M | -3.23M |
| Selling general administrative | 12.27M | 10.15M | 9.25M | 9.41M | 9.93M |
| Gross profit | 16.59M | 13.86M | 12.30M | 10.82M | 11.11M |
| Reconciled depreciation | 2.29M | 2.30M | 2.60M | 2.67M | 3.08M |
| Ebit | - | - | - | -1.26M | -1.84M |
| Ebitda | - | - | - | -0.58M | 0.71M |
| Operating income | 2.04M | 1.41M | 0.44M | -1.26M | -1.84M |
| Interest expense | 0.90M | 0.94M | 0.93M | 0.83M | 0.88M |
| Tax provision | 0.36M | 0.21M | 0.25M | 0.19M | -0.02M |
| Interest income | - | 0.00M | 0.01M | 0.02M | 0.03M |
| Net interest income | -0.90M | -0.94M | -0.92M | -0.81M | -0.84M |
| Income tax expense | - | - | - | 0.19M | -0.02M |
| Total revenue | 87.19M | 72.81M | 66.10M | 62.65M | 60.86M |
| Total operating expenses | 85.16M | 71.40M | 65.66M | 63.91M | 62.70M |
| Cost of revenue | 70.60M | 58.95M | 53.80M | 51.83M | 49.75M |
| Total other income expense net | -1.20M | -0.74M | 0.53M | -2.02M | -0.56M |
| Net income from continuing ops | -0.41M | -0.48M | -0.19M | -4.28M | -3.23M |
| Net income applicable to common shares | - | - | - | -4.17M | -3.23M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 45.09M | 41.30M | 41.78M | 45.09M | 51.34M |
| Intangible assets | 0.58M | 0.63M | 0.71M | 1.00M | 3.05M |
| Other current assets | 0.75M | 0.53M | 0.61M | 0.67M | 0.99M |
| Total liab | 24.14M | 19.87M | 19.94M | 23.43M | 25.51M |
| Total stockholder equity | 20.62M | 21.40M | 22.05M | 21.78M | 25.83M |
| Other current liab | - | - | - | 0.43M | 0.61M |
| Common stock | - | - | - | 39.92M | 36.83M |
| Capital stock | 43.56M | 44.05M | 44.13M | 39.92M | 36.83M |
| Retained earnings | -27.47M | -26.75M | -26.02M | -25.91M | -21.77M |
| Other liab | - | - | - | 0.03M | 0.21M |
| Good will | 20.75M | 20.75M | 20.72M | 20.72M | 20.72M |
| Other assets | - | - | - | 0.74M | 0.61M |
| Cash | 4.47M | 2.92M | 3.18M | 1.52M | 5.90M |
| Total current liabilities | 12.77M | 15.38M | 9.15M | 13.87M | 13.71M |
| Net debt | 1.70M | 2.83M | 2.46M | 5.25M | 2.50M |
| Short long term debt | 0.65M | 5.76M | 0.20M | 3.09M | 3.44M |
| Other stockholder equity | - | - | - | 4.88M | 9.16M |
| Property plant equipment | - | - | - | 11.54M | 11.60M |
| Total current assets | 13.89M | 11.12M | 10.66M | 11.08M | 15.37M |
| Net tangible assets | - | - | - | 0.06M | 2.06M |
| Net receivables | 8.67M | 7.43M | 6.66M | 8.89M | 8.47M |
| Long term debt | 5.53M | - | 5.44M | 3.67M | 4.96M |
| Accounts payable | 10.87M | 8.45M | 7.54M | 8.80M | 7.53M |
| Non currrent assets other | 0.38M | 0.52M | 0.62M | 0.74M | 0.61M |
| Non current assets total | 31.20M | 30.18M | 31.12M | 34.01M | 35.98M |
| Capital lease obligations | 6.96M | 5.59M | 6.48M | 7.40M | 8.00M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -1.11M | 1.59M | -1.67M | -3.50M |
| Change to liabilities | - | - | - | 0.00M | 0.40M |
| Total cashflows from investing activities | - | - | - | -1.67M | -3.50M |
| Net borrowings | -1.39M | -1.85M | -3.21M | -3.70M | -3.60M |
| Total cash from financing activities | -1.59M | -1.75M | -2.96M | -3.45M | -3.37M |
| Change to operating activities | - | - | - | 0.24M | -0.15M |
| Net income | -0.72M | -0.73M | -0.11M | -4.17M | -3.23M |
| Change in cash | 1.55M | -0.25M | 1.66M | -4.39M | -4.95M |
| Begin period cash flow | 2.92M | 3.18M | 1.52M | 5.90M | 10.85M |
| End period cash flow | 4.47M | 2.92M | 3.18M | 1.52M | 5.90M |
| Total cash from operating activities | 4.00M | 2.61M | 3.03M | 0.74M | 1.92M |
| Depreciation | 2.29M | 2.30M | 2.60M | 2.67M | 3.08M |
| Change to account receivables | -1.00M | -0.79M | 2.02M | -0.42M | 0.49M |
| Sale purchase of stock | -0.23M | -0.02M | 0.00M | - | - |
| Other cashflows from financing activities | - | - | - | 0.25M | 0.24M |
| Change to netincome | - | - | - | 2.00M | 0.89M |
| Capital expenditures | 0.86M | 0.95M | 0.35M | 1.23M | 0.41M |
| Change in working capital | 1.30M | -0.04M | 0.56M | 0.24M | 1.18M |
| Stock based compensation | 0.23M | 0.10M | 0.18M | 0.10M | 0.52M |
| Other non cash items | 0.56M | 0.77M | 0.68M | 0.10M | 0.64M |
| Free cash flow | 3.14M | 1.66M | 2.68M | -0.93M | 1.17M |
Sector: Healthcare Industry: Medical Care Facilities
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| NPTH NeuPath Health Inc |
0.01 1.85% |
0.55 | - | 7.75 | 0.39 | 1.69 | 0.50 | 13.93 |
| NLH Nova Leap Health Corp |
0.01 3.12% |
0.49 | - | 20.49 | 1.08 | 1.30 | 0.83 | 24.88 |
| KDA KDA Group Inc |
0.01 10.00% |
0.06 | - | - | 72.57 | 2.93 | 85.92 | 23.03 |
| JNH Jack Nathan Medical Corp |
- -% |
0.01 | - | - | 0.25 | 7.84 | 0.64 | -1.92 |
| ELM Element Lifestyle Retirement Inc |
- -% |
0.01 | - | - | 0.63 | 174.48 | 2.12 | 11.33 |
NeuPath Health Inc. provides chronic pain management services in Canada. It operates a network of medical clinics in Ontario and Alberta that offer assessments and rehabilitation services to patients with chronic pain, musculoskeletal/back injuries, sports-related injuries, and concussions. The company also provides workplace health services and independent medical assessments to employers and disability insurers, as well as legal practices through a network of health care providers comprising cardiologists, dentists, dermatologists, endocrinologists, psychiatrists, gastroenterologists, general practitioners, internal medicine specialists, neurologists, neuropsychiatrists, neuropsychologists, occupational therapists, ophthalmologists, orthopedic surgeons, physiatrists, physiotherapists, psychologists, respirologists, and rheumatologists. In addition, it operates a network of healthcare clinics and related businesses. The company is headquartered in Mississauga, Canada.
| Name | Title | Year Born |
|---|---|---|
| Mr. Joseph Andrew Walewicz MBA | Interim CEO & Director | 1969 |
| Mr. Jeff Zygouras C.A., CPA | CFO & Corp. Sec. | NA |
| Bjorn Thies | VP of People & Culture | NA |
| Mr. Joseph Andrew Walewicz MBA | CEO & Director | 1969 |
| Mr. Jeff Zygouras C.A., CPA | CFO & Corporate Secretary | NA |
| Bjorn Thies | Vice President of People & Culture | NA |
| Mr. Stephen L. Lemieux BA, CPA, CA, CPA, MMPA | President | 1977 |
| Ms. Geeta Vadgama | Vice President of Operations | NA |
| Mr. Stephen L. Lemieux BA, CPA, CA, MMPA | President | 1976 |
| Mr. Sandee Dela Cruz | Chief Information Officer | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.